|
Suppliers for CAS
606143-52-6
|
Properties | | CAS |
606143-52-6 | | Formula |
C17H15BrClFN4O3 |
|
|
12 Registered suppliers
U-Chemo Scientific (Shanghai) Co.,Ltd.
P.R.China
Capot Chemical Co., Ltd.
P.R.China
More details are to be found here
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C17H15BrClFN4O3
Molecular Weight: 457.685
HS Code: 29349990
Shandong Ench Chemical Co.,Ltd
P.R.China
| Appearance | Beige powder.
| | Purity | 99% min |
Aea.ltd
P.R.China
| Appearance | Beige powder.
| | Purity | 99% min |
| Appearance | Beige powder.
| | Purity | 99% min |
Hangzhou Zhongqi Chem Co., Ltd
P.R.China
| Appearance | Beige powder.
| | Purity | 99% min |
Finetech Industry Limited
P.R.China
More details are to be found here
BOC Sciences
USA
Description : Selumetinib, also known as AZD6244, is an orally bioavailable small molecule with potential antineoplastic activity. Selumetinib inhibits mitogen-activated protein kinase kinases (MEK or MAPK/ERK kinases) 1 and 2, which may prevent the activation of MEK1/2-dependent effector proteins and transcription factors, and so may inhibit cellular proliferation in MEK-overexpressing tumor cells. MEK 1 and 2 are dual-specificity kinases that are essential mediators in the activation of the RAS/RAF/MEK/ERK pathway, are often upregulated in various tumor cell types, and are drivers of diverse cellular activities, including cellular proliferation. Check for active clinical trials or closed clinical trials using this agent. - Molecular Weight :457.684
- Purity :> 98%
Molecular Formula : C17H15BrClFN4O3 Canonical SMILES : CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO
InChI :
InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)
InChIKey :
CYOHGALHFOKKQC-UHFFFAOYSA-N
Appearance :
white solid powder
Storage : Powder stores in -20ēC directly, which is effective for a period of 2 years.
Synonyms :
ARRY-142886; ARRY 142886; ARRY142886; AZD6244; AZD-6244; AZD 6244; ARRY-886; ARRY886; ARRY 886
More details are to be found here
AK Scientific, Inc.
USA
Description : Selumetinib, also known as AZD6244, is an orally bioavailable small molecule with potential antineoplastic activity. Selumetinib inhibits mitogen-activated protein kinase kinases (MEK or MAPK/ERK kinases) 1 and 2, which may prevent the activation of MEK1/2-dependent effector proteins and transcription factors, and so may inhibit cellular proliferation in MEK-overexpressing tumor cells. MEK 1 and 2 are dual-specificity kinases that are essential mediators in the activation of the RAS/RAF/MEK/ERK pathway, are often upregulated in various tumor cell types, and are drivers of diverse cellular activities, including cellular proliferation. Check for active clinical trials or closed clinical trials using this agent. - Molecular Weight :457.684
- Purity :> 98%
Molecular Formula : C17H15BrClFN4O3 Canonical SMILES : CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO
InChI :
InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)
InChIKey :
CYOHGALHFOKKQC-UHFFFAOYSA-N
Appearance :
white solid powder
Storage : Powder stores in -20ēC directly, which is effective for a period of 2 years.
Synonyms :
ARRY-142886; ARRY 142886; ARRY142886; AZD6244; AZD-6244; AZD 6244; ARRY-886; ARRY886; ARRY 886
More details are to be found here
Chemtour Biotech Co., Ltd
P.R.China
Description : Selumetinib, also known as AZD6244, is an orally bioavailable small molecule with potential antineoplastic activity. Selumetinib inhibits mitogen-activated protein kinase kinases (MEK or MAPK/ERK kinases) 1 and 2, which may prevent the activation of MEK1/2-dependent effector proteins and transcription factors, and so may inhibit cellular proliferation in MEK-overexpressing tumor cells. MEK 1 and 2 are dual-specificity kinases that are essential mediators in the activation of the RAS/RAF/MEK/ERK pathway, are often upregulated in various tumor cell types, and are drivers of diverse cellular activities, including cellular proliferation. Check for active clinical trials or closed clinical trials using this agent. - Molecular Weight :457.684
- Purity :> 98%
Molecular Formula : C17H15BrClFN4O3 Canonical SMILES : CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO
InChI :
InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)
InChIKey :
CYOHGALHFOKKQC-UHFFFAOYSA-N
Appearance :
white solid powder
Storage : Powder stores in -20ēC directly, which is effective for a period of 2 years.
Synonyms :
ARRY-142886; ARRY 142886; ARRY142886; AZD6244; AZD-6244; AZD 6244; ARRY-886; ARRY886; ARRY 886
More details are to be found here
CM Fine Chemicals
Switzerland
Description : Selumetinib, also known as AZD6244, is an orally bioavailable small molecule with potential antineoplastic activity. Selumetinib inhibits mitogen-activated protein kinase kinases (MEK or MAPK/ERK kinases) 1 and 2, which may prevent the activation of MEK1/2-dependent effector proteins and transcription factors, and so may inhibit cellular proliferation in MEK-overexpressing tumor cells. MEK 1 and 2 are dual-specificity kinases that are essential mediators in the activation of the RAS/RAF/MEK/ERK pathway, are often upregulated in various tumor cell types, and are drivers of diverse cellular activities, including cellular proliferation. Check for active clinical trials or closed clinical trials using this agent. - Molecular Weight :457.684
- Purity :> 98%
Molecular Formula : C17H15BrClFN4O3 Canonical SMILES : CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO
InChI :
InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)
InChIKey :
CYOHGALHFOKKQC-UHFFFAOYSA-N
Appearance :
white solid powder
Storage : Powder stores in -20ēC directly, which is effective for a period of 2 years.
Synonyms :
ARRY-142886; ARRY 142886; ARRY142886; AZD6244; AZD-6244; AZD 6244; ARRY-886; ARRY886; ARRY 886
More details are to be found here
Santa Cruz Biotechnology, Inc.
USA
Description : Selumetinib, also known as AZD6244, is an orally bioavailable small molecule with potential antineoplastic activity. Selumetinib inhibits mitogen-activated protein kinase kinases (MEK or MAPK/ERK kinases) 1 and 2, which may prevent the activation of MEK1/2-dependent effector proteins and transcription factors, and so may inhibit cellular proliferation in MEK-overexpressing tumor cells. MEK 1 and 2 are dual-specificity kinases that are essential mediators in the activation of the RAS/RAF/MEK/ERK pathway, are often upregulated in various tumor cell types, and are drivers of diverse cellular activities, including cellular proliferation. Check for active clinical trials or closed clinical trials using this agent. - Molecular Weight :457.684
- Purity :> 98%
Molecular Formula : C17H15BrClFN4O3 Canonical SMILES : CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO
InChI :
InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)
InChIKey :
CYOHGALHFOKKQC-UHFFFAOYSA-N
Appearance :
white solid powder
Storage : Powder stores in -20ēC directly, which is effective for a period of 2 years.
Synonyms :
ARRY-142886; ARRY 142886; ARRY142886; AZD6244; AZD-6244; AZD 6244; ARRY-886; ARRY886; ARRY 886
More details are to be found here
|
details
details